text: <unk>  is a non-nucleoside reverse transcriptase inhibitor that is FDA approved for the treatment of HIV-1 in adults and children at least 3 months old and weighing at least 3.5 kg.   Common adverse reactions include impaired concentration, abnormal dreams, rash, dizziness, nausea, headache, fatigue, insomnia and vomiting.
option_0: Efavirenz
option_1: Saquinavir
option_2: Zidovudine
option_3: Lamivudine
option_4: Entecavir
option_5: Fosamprenavir
option_6: Telbivudine
option_7: Nelfinavir